文献速递食管与纵隔外科

机器人辅助与视频辅助胸腺切除术:当前证据的叙述性综述

Robot-Assisted Versus Video-Assisted Thymectomy: A Narrative Review of Current Evidence.
PubMed 文献 · Eur J Cardiothorac Surg · 2026-01-01

该叙述性综述比较了机器人辅助胸腺切除术(RATS)与视频辅助胸腺切除术(VATS)及开放手术在胸腺上皮肿瘤和重症肌无力(MG)中的证据。在早期胸腺瘤和MG中,VATS与RATS均达到R0切除率≥95%,复发结局与胸骨切开术相当;RATS出血更少、中转更少、恢复更快,但单例成本更高。VATS对简单病例仍高效,RATS可安全扩展微创适应证至解剖复杂场景,采用应基于指征和资源考量。

要点

  • 早期胸腺瘤和MG中,VATS与RATS的R0切除率≥95%,复发结局与胸骨切开术相当。
  • RATS出血更少、中转更少、恢复更快,在肥胖或再次手术病例中优势尤其明显。
  • RATS单例成本更高,主要来自器械和平台费用,采用应基于指征和资源考量。

核心结论

  • VATS对简单病例仍高效,RATS可安全扩展微创适应证至解剖复杂场景并保持肿瘤学完整性。
  • 微创入路长期生存似乎等效,无证据显示RATS具有肿瘤学优越性。
  • RATS采用应基于指征驱动和资源考量。

研究设计与样本

  • 结构化叙述性综述,纳入多机构队列、基于登记的倾向匹配研究和系统综述。
  • 证据按肿瘤特征、特殊人群(MG、肥胖、复发胸腺瘤)、围术期与长期结局、外科医生相关因素及成本效果组织。

主要发现

  • 早期胸腺瘤和MG中,VATS与RATS均达到R0切除率≥95%,复发结局与胸骨切开术相当。
  • RATS与更少出血、更少中转和更快恢复的信号相关,在肥胖或再次手术病例中优势尤其明显。
  • 微创入路长期生存似乎等效,无证据显示RATS具有肿瘤学优越性。
  • RATS单例成本更高,主要来自器械和平台费用。

关键数值与推荐

  • 早期胸腺瘤和MG中,VATS与RATS的R0切除率≥95%。
  • RATS单例成本更高,主要来自器械和平台费用。

临床怎么用

  • 简单病例可优先选择VATS,解剖复杂场景可考虑RATS以扩展微创适应证。
  • RATS采用应基于指征和资源考量。

局限性

  • 需要进一步多中心研究,包含长期随访、患者报告结局和成本效果分析,以明确RATS在胸腺切除术中的可持续角色。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Minimally invasive thymectomy has transformed the surgical management of thymic epithelial tumours and myasthenia gravis (MG). Video-assisted thoracoscopic surgery (VATS) is well established, whereas robot-assisted thoracoscopic surgery (RATS) provides technical and ergonomic advantages but at a higher cost. We reviewed current evidence to clarify the indications, oncological validity, perioperative performance, and economic implications of RATS compared with VATS and open thymectomy. METHODS: A structured narrative review was conducted, drawing on multi-institutional cohorts, registry-based propensity-matched studies, and systematic reviews. Evidence was organized by tumour characteristics, special populations (MG, obesity, recurrent thymoma), perioperative and long-term outcomes, surgeon-centred considerations, and cost-effectiveness. RESULTS: In early-stage thymoma and MG, both VATS and RATS achieve R0 resection rates ≥95% and recurrence outcomes comparable with sternotomy. Robot-assisted thoracoscopic surgery is associated with lower blood loss, fewer conversions, and signals of faster recovery, with particular advantages in obese or redo cases. Long-term survival appears equivalent across minimally invasive approaches, without evidence of oncological superiority. However, RATS incurs higher per-case costs, primarily from instrumentation and platform expenses. CONCLUSIONS: VATS remains efficient for straightforward cases, whereas RATS may safely extend minimally invasive eligibility to anatomically complex scenarios while maintaining oncological integrity. Adoption should be indication-driven and resource-conscious. Further multicentre studies with long-term follow-up, patient-reported outcomes, and cost-effectiveness analyses are needed to define the sustainable role of RATS in thymectomy. CLINICAL REGISTRATION NUMBER: Not applicable.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Bae SY, Na KJ. Robot-Assisted Versus Video-Assisted Thymectomy: A Narrative Review of Current Evidence. Eur J Cardiothorac Surg. 2026. PMID: 42102247. doi:10.1093/ejcts/ezag005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。